^
    The Myriad myRisk® Hereditary Cancer test is a 35-gene panel that identifies an elevated risk for eight hereditary cancers: Breast, Ovarian, Gastric, Colorectal, Pancreatic, Melanoma, Prostate, Endometrial. One key feature is the test result that providers and patients receive. Instead of a test result indicating only whether the patient is positive or negative for a gene mutation, the myRisk test provides a clinical decision support tool. This tool outlines patients’ cancer risks and the medical management recommendations endorsed by societal guidelines.
    Cancer:
    Breast Cancer, Colorectal Cancer, Endometrial Cancer, Gastric Cancer, Melanoma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer
    Gene:
    APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), BARD1 (BRCA1 Associated RING Domain 1), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1)
    See More ...
    Method:
    Next-Generation Sequencing (NGS)